{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:00:18Z","timestamp":1773313218958,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12029-021-00726-7","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T05:02:25Z","timestamp":1635138145000},"page":"1093-1103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cost-Effectiveness of Screening Helicobacter pylori for Gastric Cancer Prevention: a Systematic Review"],"prefix":"10.1007","volume":"53","author":[{"given":"Maryam","family":"Sarmasti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manouchehr","family":"Khoshbaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-5040","authenticated-orcid":false,"given":"Mahmood","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"726_CR1","doi-asserted-by":"crossref","unstructured":"Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. The lancet oncology. 2008;9(3):279\u201387.","DOI":"10.1016\/S1470-2045(08)70072-X"},{"issue":"8","key":"726_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study. Lancet Oncol. 2012;13(8):790\u2013801.","journal-title":"Lancet Oncol"},{"issue":"9","key":"726_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ng.3052","volume":"46","author":"BM Wolpin","year":"2014","unstructured":"Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014;46(9):994\u20131000.","journal-title":"Nat Genet"},{"key":"726_CR4","doi-asserted-by":"crossref","unstructured":"Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113\u201324. e5.","DOI":"10.1053\/j.gastro.2016.01.028"},{"key":"726_CR5","doi-asserted-by":"crossref","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020.","DOI":"10.1002\/14651858.CD005583.pub3"},{"key":"726_CR6","unstructured":"Humans IWGotEoCRt. schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog. Risks Hum. 1994;61:177\u2013240."},{"issue":"2","key":"726_CR7","first-page":"33","volume":"9","author":"R Pounder","year":"1995","unstructured":"Pounder R, Ng D. The prevalence of Helicobacter pylori infection in different countries. Alimentary pharmacology & therapeutics Supplement. 1995;9(2):33\u20139.","journal-title":"Alimentary pharmacology & therapeutics Supplement"},{"issue":"5","key":"726_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence consensus report. Gut. 2012;61(5):646\u201364.","journal-title":"Gut"},{"issue":"6","key":"726_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C De Martel","year":"2012","unstructured":"De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607\u201315.","journal-title":"Lancet Oncol"},{"issue":"2","key":"726_CR10","first-page":"66","volume":"10","author":"G Kaur","year":"2003","unstructured":"Kaur G, Naing NN. Prevalence and ethnic distribution of Helicobacter pylori infection among endoscoped patients in North Eastern Peninsular Malaysia. The Malaysian journal of medical sciences: MJMS. 2003;10(2):66.","journal-title":"The Malaysian journal of medical sciences: MJMS"},{"issue":"2","key":"726_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2036.2006.03183.x","volume":"25","author":"L Fuccio","year":"2007","unstructured":"Fuccio L, Zagari R, Minardi M, Bazzoli F. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther. 2007;25(2):133\u201341.","journal-title":"Aliment Pharmacol Ther"},{"key":"726_CR12","unstructured":"Fashner J, Gitu AC. Diagnosis and treatment of peptic ulcer disease and H. pylori infection. Am Fam Physician. 2015;91(4):236\u201342."},{"key":"726_CR13","doi-asserted-by":"crossref","unstructured":"Talebi Bezmin Abadi A. Diagnosis of Helicobacter pylori using invasive and noninvasive approaches. J Pathog.\u00a02018;2018.","DOI":"10.1155\/2018\/9064952"},{"issue":"1","key":"726_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"key":"726_CR15","unstructured":"Organization WH. Table: Threshold values for intervention cost-effectiveness by Region. World Health Organization Available: http:\/\/www.who\/int\/choice\/costs\/CER_levels\/en\/index html Accessed. 2013;7."},{"key":"726_CR16","unstructured":"Clinical If, Review E. Overview of the ICER value assessment framework and update for 2017\u20132019. 2018."},{"key":"726_CR17","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015."},{"issue":"9021","key":"726_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0140-6736(96)01501-2","volume":"348","author":"J Parsonnet","year":"1996","unstructured":"Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. The Lancet. 1996;348(9021):150\u20134.","journal-title":"The Lancet"},{"issue":"1","key":"726_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.23864","volume":"124","author":"JM Yeh","year":"2009","unstructured":"Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer. 2009;124(1):157\u201366.","journal-title":"Int J Cancer"},{"issue":"19","key":"726_CR20","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3748\/wjg.14.3021","volume":"14","author":"F Xie","year":"2008","unstructured":"Xie F, Luo N, Lee H-P. Cost effectiveness analysis of population-based serology screening and 13C-urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model. World J Gastroenterol: WJG. 2008a;14(19):3021.","journal-title":"World J Gastroenterol: WJG"},{"issue":"6 Suppl 7","key":"726_CR21","first-page":"S13","volume":"20","author":"O Wong","year":"2014","unstructured":"Wong O, Schooling C, Cowling B. Cost-effectiveness of Helicobacter pylori screening and. Hong Kong Med J. 2014;20(6 Suppl 7):S13\u20135.","journal-title":"Hong Kong Med J"},{"issue":"1","key":"726_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S0266462307080117","volume":"24","author":"F Xie","year":"2008","unstructured":"Xie F, Luo N, Blackhouse G, Goeree R, Lee H-P. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Int J Technol Assess Health Care. 2008b;24(1):87.","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"726_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/archinte.159.2.142","volume":"159","author":"AM Fendrick","year":"1999","unstructured":"Fendrick AM, Chernew ME, Hirth RA, Bloom BS, Bandekar RR, Scheiman JM. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med. 1999;159(2):142\u20138.","journal-title":"Arch Intern Med"},{"issue":"5","key":"726_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacr.2009.01.022","volume":"6","author":"F Xie","year":"2009","unstructured":"Xie F, O\u2019Reilly D, Ferrusi IL, Blackhouse G, Bowen JM, Tarride J-E, et al. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol. 2009;6(5):317\u201323.","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"726_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12879-017-2259-2","volume":"17","author":"AM Teng","year":"2017","unstructured":"Teng AM, Kvizhinadze G, Nair N, McLeod M, Wilson N, Blakely T. A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity. BMC Infect Dis. 2017;17(1):156.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"726_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/hel.12050","volume":"18","author":"M Areia","year":"2013","unstructured":"Areia M, Carvalho R, Cadime AT, Rocha Gon\u00e7alves F, Dinis-Ribeiro M. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter. 2013;18(5):325\u201337.","journal-title":"Helicobacter"},{"issue":"6","key":"726_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bpg.2013.09.005","volume":"27","author":"I Lansdorp-Vogelaar","year":"2013","unstructured":"Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol. 2013;27(6):933\u201347.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"726_CR28","first-page":"121","volume":"34","author":"H Ameri","year":"2020","unstructured":"Ameri H, Safari H, Yousefi M. Interim value set for the EQ-5D-5L in Iran using the Crosswalk method. Med J Islam Repub Iran. 2020;34:121.","journal-title":"Med J Islam Repub Iran"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00726-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-021-00726-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00726-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T19:22:11Z","timestamp":1667416931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-021-00726-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["726"],"URL":"https:\/\/doi.org\/10.1007\/s12029-021-00726-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"3 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}